VivoSim Labs has extended its human tissue platform to include efficacy testing for liver and intestinal diseases using patient-derived cells. This new service allows drug developers to assess whether drug candidates effectively target disease features before clinical trials, addressing a major cause of trial failures—lack of efficacy. The platform includes models for metabolic dysfunction-associated steatohepatitis (MASH) and inflammatory bowel diseases like ulcerative colitis and Crohn’s disease. VivoSim’s approach combines safety and efficacy testing on the same human tissue models, potentially doubling its market reach and improving drug development success rates.
VivoSim Labs' expansion of its NAMkind platform introduces new human disease models for drug efficacy testing. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 21, 2026 18:42 WIB: out of 150 priced US health stocks, 65 rose and 76 fell. Notable movers include BioNano Genomics Inc (BNGO) at USD 1.21 with a 2.81% decline and 100% sell order activity, Cencora Inc. (COR) at USD 334.00 down 2.70%, and Zimmer Biomet Holdings Inc (ZBH) at USD 93.60 down 2.50% with full sell order activity. Typical hold times vary from 6 to 89 days on Pluang.
The BBB National Programs’ National Advertising Division reviewed Royal Caribbean Group's advertising related to gratuities and found the company's recent modifications to be supported. Royal Caribbean clarified in its booking process that gratuities...
Deutsche Bank increased its price target for Kroger to $70 from $68, reflecting a potential 10.7% upside. Kroger announced strategic growth initiatives including a $5 billion customer-value investment and plans to open 110 new stores by 2029. The com...
Crown Castle is set to report its Q3 2026 earnings with Wall Street expecting a 5.9% revenue decline to about $1.01 billion, mainly due to drops in site rental and services revenue. However, some forecasts predict a 7.1% rise in earnings per share to...
PypeServer has released Cloud+ version 3.0, enabling HVAC contractors to manage both ductwork and piping fabrication on a single platform. This update allows seamless tracking from design through installation, integrating with existing design softwar...
Kevel secured $52 million in its largest funding round to date, boosting its AI-powered infrastructure for commerce media networks. The capital will accelerate product innovation, transparent AI decisioning, and global expansion, helping retailers an...
